Hey Smitty, that's all ACTC ever does huh? Oh, I guess those pesky trials and in depth researcher must just be window dressing. Silly me and the rest of the world, we all thought they were trying to solve and help cure many serious health issues with their research. Wow, if we had only listened to you, you and your girl/guy Karen. I guess now we all know the truth, all ACTC does is presentations. You're brilliant !!! Hey Capt, I have this bridge in NYC you might be interested in. Due to your humanitarian actions and knowledge you ever so kindly shared with us here, I'll sell you the bridge for half ow what I'd charge others. RSVP.
Unfortunately, Matt Vincent is usually the presenter for actc. He speaks well, better than GR......but, deep pocket bio-tech venture capitalists typically do their homework before investing millions in new, speculative bio-tech, and sometimes, they simply google the words Mathew Vincent attorney. In a few minutes they've decided this is a scam. We know actc is not a scam, though it has real management "issues", but anyone googling Mathew Vincent would think otherwise.
All I could find was some cat named Emund Mickunas, vice president, Regulatory Affairs, Advanced Cell Technologies-those nerds on that site need to get a better web designer to tweek that site a give it a better "search" option. I don't think ACTC has a very outstanding presentation there and I doubt it will make a bit of difference. Althugh I guess the combined exposure of all of these ACTC presentation can't hurt.
Verify it-your memory and numbers are convenient. What really happens is day trading-buy on the rumor, sell on the news". three days prior pps goes up-when there is nothing earth moving announced (truthfully-why would he wait to announce that kind of news, so why expect it at a meeting?) after he speaks the pps goes back or lower. It's a sell-off w/ minor shorting.